From CFTR modulators to gene therapy, what's next in cystic fibrosis research? Peter Mogayzel examines future therapies, ongoing access challenges, and the crucial link between advocacy, innovation, and global health equity in cystic fibrosis care.

Timestamps:

00:00 – Introduction

01:05 - CFTR modulators

03:35 – Anti-inflammatory drugs

04:18 – mRNA therapy

04:53 – Side effects

07:13 – Access to care

08:37 – Exercise

10:00 – Final thoughts